What is the 13F Pro Quality Score for CITR?

13F Pro ranks CitroTech Inc. (CITR) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View CITR's current score at https://13fpro.ai/research/CITR (free sign-up required for the full ranking).

Where does 13F Pro source CITR data?

All CitroTech Inc. fundamentals and ownership data come directly from SEC EDGAR. CitroTech Inc. files with the SEC under CIK 894556. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is CITR in?

CitroTech Inc. (CITR) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is CITR research updated on 13F Pro?

CITR's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

CitroTech Inc.(CITR)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →NYSE

Institutional-grade research for retail investors

SEC EDGAR: CIK 894556 CITR stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Below size threshold

Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $2.4M in revenue.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

CITR Stock Analysis & AI Quality Score

AI stock analysis and institutional research for CitroTech Inc. (CITR), a Healthcare sector company. CITR is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $2.4m in revenue. Based on the latest XBRL financial filings (Q1 2026), CitroTech Inc. reports quarterly revenue of $344.9K, net income of $-6.2M, free cash flow of $-2.1M. Top institutional holders of CITR by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, GEODE CAPITAL MANAGEMENT,, FIFTH THIRD BANCORP, based on the most recent SEC filings. CITR trades on the NYSE exchange and files with the SEC under CIK 894556. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CITR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CitroTech Inc. directly from SEC EDGAR.

Revenue

Q1 2026

$344.9K

Net Income

Q1 2026

$-6.2M

Free Cash Flow

Q1 2026

$-2.1M

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+357.4% YoY

$2.4MFY 2025

FY20 —FY21 $0.00FY23 $520.6KFY25 $2.4M

Net Income

-264.6% YoY

$-36.8MFY 2025

FY20 $-109.4KFY21 $-95.0KFY23 $-10.1MFY25 $-36.8M

Operating Income

-63.4% YoY

$-16.5MFY 2025

FY20 $-109.4KFY21 $-37.9KFY23 $-10.1MFY25 $-16.5M

EPS (Diluted)

-2860.0% YoY

$-2.96FY 2025

FY20 —FY21 $0.00FY23 $-0.10FY25 $-2.96

Total Assets

+167.5% YoY

$14.2MFY 2025

FY20 $0.00FY21 $330.2KFY23 $5.3MFY25 $14.2M

Total Debt

—FY 2025

FY20 —FY21 —FY23 $0.00FY25 —

Op. Cash Flow

-384.3% YoY

$-5.9MFY 2025

FY20 $0.00FY21 $-24.2KFY23 $-1.2MFY25 $-5.9M

Metric	FY 2025	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018
Revenue	$2.4M +357.4%	$520.6K	$0.00	—	—	—
Net Income	$-36.8M -264.6%	$-10.1M -10537.0%	$-95.0K +13.2%	$-109.4K	$0.00	—
Operating Income	$-16.5M -63.4%	$-10.1M -26537.3%	$-37.9K +65.3%	$-109.4K	—	—
EPS (Diluted)	$-2.96 -2860.0%	$-0.10	$0.00	—	—	—
Total Assets	$14.2M +167.5%	$5.3M +1505.9%	$330.2K	$0.00	$0.00	—
Total Debt	—	$0.00	—	—	—	—
Operating Cash Flow	$-5.9M -384.3%	$-1.2M -4906.0%	$-24.2K	$0.00	$0.00	—

AI Insight: CITR Financial Trends

CitroTech remains pre-revenue with mounting operating losses and negative cash burn, despite modest equity raises.

• Revenue near zero across all periods; Q1 2025–Q2 2025 showed $1M quarterly revenue, now back to $0M.

• Net losses widened from $1M in Q2 2024 to $12M in Q2 2025, then moderated to $6M in Q1 2026.

• Operating cash outflow stable at ~$1–2M per quarter; equity increased from $3M (Q2 2024) to $9M (Q1 2026).

⚠ Operating margin deteriorated sharply: $1M loss in Q2 2024 widened to $6M loss in Q4 2025 on zero revenue.

⚠ Equity volatility: spiked to $11M in Q4 2025, then contracted to $9M in Q1 2026—suggests capital adjustments or dilution.

AI Insight: CITR Ratio Trends

Profitability metrics remain severely depressed with sparse recent data; leverage stabilized near zero but earnings recovery unconfirmed.

• ROE and ROA were deeply negative in Q2–Q3 2024 (ROE −112.9% to −92.5%, ROA −67.8% to −53.0%), with no profitability data available since.

• Debt-to-equity ratio collapsed from 0.06 in Q4 2024 to 0.00 in Q1–Q2 2025, signaling deleveraging or debt elimination.

⚠ Complete absence of profitability ratios (OpMargin, NPM, ROE, ROA, ROIC) from Q4 2024 onward suggests either data gaps or ongoing losses; earnings recovery path unclear.

Get alerted when CITR's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for CitroTech Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of CITR

VANGUARD CAPITAL MANAGEMENT LLC
$3.7M424,168 sh
GEODE CAPITAL MANAGEMENT, LLC
$1.3M152,541 sh
FIFTH THIRD BANCORP
$1.0M121,170 sh
Lotus Technology Management, LP
$750.0K750,000 sh
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$717.9K83,185 sh
VANGUARD FIDUCIARY TRUST CO
$580.0K67,206 sh
MILLENNIUM MANAGEMENT LLC
$486.1K56,321 sh
NORTHERN TRUST CORP
$226.4K26,231 sh
T3 Companies, LLC
$215.8K25,000 sh
STATE STREET CORP
$100.5K11,650 sh

Fund	Value	Shares
VANGUARD CAPITAL MANAGEMENT LLC	$3.7M	424,168
GEODE CAPITAL MANAGEMENT, LLC	$1.3M	152,541
FIFTH THIRD BANCORP	$1.0M	121,170
Lotus Technology Management, LP	$750.0K	750,000
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$717.9K	83,185
VANGUARD FIDUCIARY TRUST CO	$580.0K	67,206
MILLENNIUM MANAGEMENT LLC	$486.1K	56,321
NORTHERN TRUST CORP	$226.4K	26,231
T3 Companies, LLC	$215.8K	25,000
STATE STREET CORP	$100.5K	11,650

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put CITR on your watchlist

Track score changes the day CitroTech Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is CITR a good stock to buy?

13F Pro's AI-powered analysis of CitroTech Inc. (CITR) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CITR are available on the CITR stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own CITR?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CITR. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of CitroTech Inc.'s investment landscape.